Leidos Holdings - LDOS STOCK NEWS

Leidos (NYSE:LDOS) announced a new prime contract valued at $76 million with the Office of Child Support Enforcement (OCSE) under the Department of Health and Human Services. This contract, effective for approximately five years if all options are exercised, will continue the company's support for OCSE's Federal Parent Locater Service (FPLS). The contract, in place since 1996, aims to enhance child support enforcement capabilities across the nation. Work will primarily take place in Maryland.

Leidos (NYSE: LDOS) has secured a three-year contract (with an optional fourth year) worth up to £70M from the UK's MOD to enhance geospatial intelligence (GEOINT) through the PICASSO programme. This initiative aims to modernize and streamline the UK's defense capabilities by integrating legacy systems into a more efficient information environment. The contract focuses on improving service delivery, user experience, and transparency, while enabling informed decision-making for national security. Leidos plans to leverage its technical expertise to support these modernization efforts.

Brooks Automation, Inc. (Nasdaq: BRKS) announced a new contract with QTC Management, a Leidos company (NYSE: LDOS), to provide vaccine storage and distribution for the U.S. Department of Defense. This collaboration supports QTC's Reserve Health Readiness Program III, ensuring secure cold storage of vaccines and timely delivery across the U.S. and Germany. Azenta Life Sciences, the rebranded segment of Brooks, will leverage its expertise in cold-chain services to meet stringent requirements. This strategic move reflects Brooks' focus on expanding its Life Sciences business.

Leidos Holdings (LDOS) reported a strong Q3 2021, with revenues reaching $3.48 billion, up 7% year-over-year. Net income increased 28% to $208 million, leading to diluted EPS of $1.43. Adjusted EBITDA rose 16% to $403 million, with an increased margin of 11.6%. The company recorded $4.7 billion in net bookings, resulting in a backlog of $34.7 billion. Leidos updated its FY21 guidance, projecting revenues between $13.7-$13.9 billion and non-GAAP diluted EPS of $6.55-$6.75.

Leidos (NYSE:LDOS) has been awarded a task order by the Air Combat Command (ACC) Acquisition Management and Integration Center, valued at approximately $531 million if all options are exercised. The contract includes a one-year base period and four one-year options, focusing on intelligence, surveillance, and reconnaissance (ISR) operations. Leidos will provide expertise and support services at over 25 locations. This contract emphasizes Leidos' strategic role in enhancing ACC's operational capabilities, leveraging over 33 years of experience in defense intelligence.

Leidos Holdings, Inc. (NYSE:LDOS) has announced a quarterly cash dividend of $0.36 per share, payable on December 30, 2021. To qualify, stockholders must be on record by the close of business on December 15, 2021. This decision reflects Leidos' ongoing commitment to return value to shareholders. The company, a leader in technology and engineering, reported annual revenues of approximately $12.30 billion for the fiscal year ending January 1, 2021, and employs around 43,000 individuals.

Leidos (NYSE: LDOS) has been awarded a prime contract by the Office of Naval Intelligence (ONI) for approximately $65 million to support the Hopper Information Services Center. This contract includes professional IT services like cloud migration, software development, and cybersecurity, primarily based in Suitland, Maryland. Leidos aims to enhance the U.S. naval forces' information advantage through this agreement, building on decades of collaboration with ONI.

Leidos (NYSE: LDOS) has announced a conference call to discuss its third-quarter financial results for the period ending October 1, 2021. The call is scheduled for November 2, 2021, at 8 a.m. ET, with the earnings press release set to be issued prior to the call. Investors can access the conference via the internet or telephone. The company reported approximately $12.30 billion in annual revenues for the fiscal year ending January 1, 2021, serving government and commercial clients across defense, intelligence, civil, and health markets.